Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports binding to various neurotransmitter receptors, making it valuable in the research of antidepressants, antipsychotics, and anxiolytic drugs. The trifluoromethylpyridine moiety enhances metabolic stability and bioavailability, which improves drug efficacy. Commonly employed in medicinal chemistry for lead optimization and structure-activity relationship (SAR) studies.